Global Embolotherapy Market is Set to Reach USD 3.6 billion by 2023, Observing a CAGR of 6.8% during 2025 - 2030

Published Date: Mar, 2024

The global embolotherapy market is expected to grow at a CAGR of 6.8% during the forecast period with its market size predicted to be USD 3.6 billion by 2030. Globally, embolotherapy industry players are undertaking considerable investment decisions and launching new products to gain a competitive advantage. Moreover, entering into partnership agreements and performing mergers & acquisitions are the key development strategies being implemented by the crucial players in the global embolotherapy market.

The hospital and clinics category held largest share of the embolotherapy market in 2023

Based on end user, the global embolotherapy market is segmented into ambulatory surgical centers (ASCs), hospitals and clinics, and others. Amongst these segments, hospitals and clinics are dominating in terms of revenue throughout the estimated period owing to extensive accessibility of reimbursement policies being implemented by hospitals and clinics and excessive adoption of these devices in small clinics, big hospitals, and critical care units.

Global Embolotherapy Market Segmentation and Key Players

Segment / Key Players

Categorization

Product

Embolic Agents [Microspheres, Embolic coils, Liquid embolic agents, Embolic plug systems, Detachable balloons], Support Devices [Microcatheters, Guidewires]

Procedure

Transcatheter Arterial Embolization [TAE], Transarterial Radioembolization/Selective Internal Radiation Therapy [TARE/SIRT], Transarterial Chemoembolization [TACE]

Indication

Cancer [Liver, Kidney, Others], Neurological Diseases [Cerebral aneurysm, Arteriovenous malformation and fistulas], Peripheral Vascular Diseases, Urological & Nephrological Disorders, Gastrointestinal Disorders

End User

Hospitals & Clinics, Ambulatory Surgical Centers [ASCs], Others

Key Players

Merit Medical Systems, Acandis GmbH, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Terumo Corporation, Stryker Corporation, Johnson & Johnson, BALT Extrusion, Sirtex Medical Limited, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Penumbra, Inc., and BTG Plc.

Browse Market Insight and In-depth TOC on "Global Embolotherapy Market - Analysis and Forecast (2025-2030)"

Geography Insight

North America has accounted for the largest share in the embolotherapy market, globally and is predicted to grow significantly during the forecast period, owing to the increasing emphasis in the region towards the development of advanced embolic agents, the extensive pervasiveness of incidents that necessitate the adoption of embolization processes. Moreover, the established healthcare system in this region is the key factor that is further anticipated to drive the growth of the embolotherapy market in this region.

Competitive Insight

Some of the players having prominent presence in the global embolotherapy market include Merit Medical Systems, Acandis GmbH, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Terumo Corporation, Stryker Corporation, Johnson & Johnson, BALT Extrusion, Sirtex Medical Limited, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Penumbra, Inc., and BTG Plc.

Key Takeaway from the Report:

  • Among all the products, the embolic agents segment held the largest share of the market in 2022.
  • Of all the procedures, the TAE segment is anticipated to generate the largest revenue throughout the estimated period.
  • Among all the indications, the cancer category held the largest share of the market in 2022.
  • Among all the end users, the hospitals and clinics category held the largest share in the embolotherapy market in 2022.

The Report Offers:

  • Historical market estimate for the years 2018–2023 and forecast for the years 2025–2030
  • Insight on current market trends, market dynamics, key opportunities and major challenges in the industry
  • Market insights by in-depth segmentation with industry dynamics.
  • Competitive analysis and benchmarking of the industry leaders and their product offerings
  • Profiles of leading players and innovators, their financial overview, and product portfolio
  • Analysis of key industry trends and recent developments
  • Value chain analysis and distribution channel analysis with opportunity assessment
  • Market share analysis of major players

Benefits of Report Purchase from VynZ:

Detailed Research

We provide accurate data and in-depth analysis with all-inclusive coverage.

Robust Research Methodology

Robust research methodology and data triangulation to ensure a high-quality report.

Analyst Support

24*7 analyst support – Pre and post-purchase of the report as well as during the project tenure.

Sales Support

24*7 sales support – Hassle-free delivery of the report and quick response and support by the sales team.

Free Customization

20% post-purchase free customization to meet your requirements.

Customer Satisfaction

We claim full customer satisfaction as our core values lie in building long-term relationships.

Security

High level of data security and confidentiality of your information.

 

The report provides the market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue (USD Billion) and Volume (Units). The report segments the global embolotherapy market based on product, procedure, indication, end user, and region.

Global Embolotherapy Market Coverage

Product Insight and Forecast 2025-2030

  • Embolic Agents
    • Microspheres
    • Embolic Coils
    • Liquid Embolic Agents
    • Embolic Plug Systems
    • Detachable Balloons
  • Support Devices
    • Microcatheters
    • Guidewires

Procedure Insight and Forecast 2025-2030

  • Transcatheter Arterial Embolization (TAE)
  • Transarterial Chemoembolization (TACE)
  • Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)

Indication Insight and Forecast 2025-2030

  • Cancer
    • Liver
    • Kidney
    • Others
  • Neurological Diseases
    • Cerebral Aneurysm
    • Arteriovenous Malformation And Fistulas
  • Peripheral Vascular Diseases
  • Urological and Nephrological Disorders
  • Gastrointestinal Disorders

End User Insight and Forecast 2025-2030

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

Geographical Segmentation

Embolotherapy Market by Region

North America

  • By Product
  • By Procedure
  • By Indication
  • By End User
  • By Country – U.S., Canada, and Mexico
    • U.S. Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Canada Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Mexico Market
      • By Product
      • By Procedure
      • By Indication
      • By End User

Europe

  • By Product
  • By Procedure
  • By Indication
  • By End User
  • By Country – Germany, U.K., France, Italy, Spain, and Rest of Europe
    • Germany Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • U.K. Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • France Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Italy Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Spain Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Rest of Europe Market
      • By Product
      • By Procedure
      • By Indication
      • By End User

Asia-Pacific (APAC)

  • By Product
  • By Procedure
  • By Indication
  • By End User
  • By Country – China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific
    • China Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Japan Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • India Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • South Korea Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Singapore Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Rest of Asia-Pacific Market
      • By Product
      • By Procedure
      • By Indication
      • By End User

Rest of the World (RoW)

  • By Product
  • By Procedure
  • By Indication
  • By End User
  • By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries
    • Brazil Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Saudi Arabia Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • South Africa Market
      • By Product
      • By Procedure
      • By Indication
      • By End User
    • Other Countries Market
      • By Product
      • By Procedure
      • By Indication
      • By End User